Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gisli Jenkins

Showing results (21-30 of 208) with videos related to

Pageof 21
Sort By:
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Will the anti-fibrotic effects of Nerandomi-Last? FIBRONEER-IPF part 2Yet H Khor, R Gisli Jenkins
Thorax|February 16, 2021
COVID-19 and what comes after?Nicholas S Hopkinson, Gisli Jenkins, Nicholas Hart
Thorax|August 7, 2019
Review of the British Thoracic Society Winter Meeting 2018, 5-7 December 2018, London, UKAmanda T Goodwin, Aran Singanayagam, Gisli Jenkins
Therapeutic Advances in Respiratory Disease|October 19, 2010
The pathogenesis of idiopathic pulmonary fibrosisWilliam R Coward, Gauri Saini, Gisli Jenkins
Thorax|June 16, 2016
First year of the thoracic triumvirateNicholas Hart, Gisli Jenkins, Alan Robert Smyth
Thorax|April 22, 2020
Preprint servers: a 'rush to publish' or 'just in time delivery' for science?Alan Robert Smyth, Claire Rawlinson, Gisli Jenkins
Methods in Molecular Biology (Clifton, N.J.)|May 24, 2021
Myofibroblast TGF-β Activation Measurement In VitroJoanne Porte, Gisli Jenkins, Amanda L Tatler
Respirology (Carlton, Vic.)|April 30, 2023
Contemporary Concise Review 2022: Interstitial lung diseaseDavid J F Smith, R Gisli Jenkins
The Journal of Clinical Investigation|September 15, 2023
Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosisJames May, Jane A Mitchell, R Gisli Jenkins
Thorax|May 6, 2017
Review of the British Thoracic Society Winter Meeting 2016, 7-9 December, London, UKHannah V Woodcock, Ricardo J José, Gisli Jenkins, et al.
Pageof 21

Showing results (21-30 of 208) with videos related to

Sort By:
Pageof 21
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Will the anti-fibrotic effects of Nerandomi-Last? FIBRONEER-IPF part 2Yet H Khor, R Gisli Jenkins
Thorax|February 16, 2021
COVID-19 and what comes after?Nicholas S Hopkinson, Gisli Jenkins, Nicholas Hart
Thorax|August 7, 2019
Review of the British Thoracic Society Winter Meeting 2018, 5-7 December 2018, London, UKAmanda T Goodwin, Aran Singanayagam, Gisli Jenkins
Therapeutic Advances in Respiratory Disease|October 19, 2010
The pathogenesis of idiopathic pulmonary fibrosisWilliam R Coward, Gauri Saini, Gisli Jenkins
Thorax|June 16, 2016
First year of the thoracic triumvirateNicholas Hart, Gisli Jenkins, Alan Robert Smyth
Thorax|April 22, 2020
Preprint servers: a 'rush to publish' or 'just in time delivery' for science?Alan Robert Smyth, Claire Rawlinson, Gisli Jenkins
Methods in Molecular Biology (Clifton, N.J.)|May 24, 2021
Myofibroblast TGF-β Activation Measurement In VitroJoanne Porte, Gisli Jenkins, Amanda L Tatler
Respirology (Carlton, Vic.)|April 30, 2023
Contemporary Concise Review 2022: Interstitial lung diseaseDavid J F Smith, R Gisli Jenkins
The Journal of Clinical Investigation|September 15, 2023
Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosisJames May, Jane A Mitchell, R Gisli Jenkins
Thorax|May 6, 2017
Review of the British Thoracic Society Winter Meeting 2016, 7-9 December, London, UKHannah V Woodcock, Ricardo J José, Gisli Jenkins, et al.
Pageof 21